Drug Discovery World

JANUARY 26, 2023

Organic chemists at t he University of California, Los Angeles (UCLA) have created the first synthetic version of a molecule recently discovered in a sea sponge that may have therapeutic benefits for Parkinson’s disease and similar disorders.

Organic Chemistry 130

Organic Chemistry Laboratories RNA DNA 130

The Pharma Data

DECEMBER 2, 2020

She is currently the CEO of Twentyeight-Seven, a biotech company focused on novel RNA biology that she co-founded alongside prominent Harvard investigators. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley. The Company’s primary target indications are type 1 diabetes (T1D) and inflammatory bowel disease (IBD).

Pharmaceuticals 52

Pharmaceuticals Synthetic Chemistry RNA Doctors 52

Dark Matter Blog

APRIL 8, 2020

Most people, and in particular most investors we spoke to in those early days, thought we were nuts – that RNA lacked the structural and molecular complexity that medicinal chemistry exploits with such great effect for proteins. One is that molecular recognition is purely a matter of physics and RNA has to play by the same rules.

RNA 52

RNA Small Molecule Synthetic Chemistry Science 52